Comparison of endotoxin antagonism of linear and cyclized peptides derived from limulus anti-lipopolysaccharide factor

Surgical Infections
Daniel B LeslieDavid L Dunn

Abstract

Limulus anti-lipopolysaccharide (LPS) factor (LALF) is a 102-amino acid LPS-binding protein from the horseshoe crab, Limulus polyphemus. The peptide includes the LPS-binding domain of holoLALF, yet it lacks the loop structure stabilized by disulfide or other covalent bonds that is a common motif in the LPS-binding regions of holo- LALF and several other LPS-binding proteins. Although it neutralizes LPS and is bactericidal against Pseudomonas aeruginosa, the LALF 28-54 portion of LALF is not protective in a murine model of intraperitoneal sepsis compared with holoLALF. We examined the effects of cyclizing this linear peptide to determine if this action would recapitulate the stable loop-type structure and enhance its LPS-neutralization and bactericidal activity in vitro. Cyclic LALF 28-54 was produced by oxidizing linear LALF 28-54. Each peptide, along with appropriate controls, was assayed for LPS neutralization using the chromogenic Limulus amebocyte lysate (LAL) assay and a bioassay to measure inhibition of LPS-stimulated production of tumor necrosis factor-alpha (TNF-alpha) by murine macrophages. Bactericidal activity against Pseudomonas aeruginosa was also assessed. Data were analyzed using a two-tailed Student t-test. Poly...Continue Reading

References

Jun 1, 1992·Infection and Immunity·H S WarrenT J Novitsky
Jan 1, 1990·International Reviews of Immunology·M A Freudenberg, C Galanos
Mar 30, 1982·Biochemical and Biophysical Research Communications·S TanakaS Iwanaga
Jun 1, 1995·Statistical Methods in Medical Research·A D CliffG D Williamson
Dec 1, 1994·The Journal of Infectious Diseases·M KloczewiakH S Warren
Jan 1, 1996·Scandinavian Journal of Infectious Diseases·M L KantanenP Leinikki
Jan 1, 1997·Advances in Immunology·C E HackL G Thijs
Feb 18, 1998·The Journal of Infectious Diseases·R I RothJ Levin
Apr 1, 1998·Protein Science : a Publication of the Protein Society·K H Mayo, E Ilyina
Jul 31, 1998·Protein Science : a Publication of the Protein Society·L J BeamerD Eisenberg
May 21, 1999·Archives of Internal Medicine·Y CarmeliM H Samore

❮ Previous
Next ❯

Citations

Feb 5, 2016·Aesthetic Surgery Journal·Dragana AjdicSeth Thaller
Jan 24, 2016·Biochimica Et Biophysica Acta·Klaus BrandenburgKarl Lohner
Jun 28, 2012·Molecular Medicine Reports·Zhen LiZhipeng Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.